Clinical trial · Observational
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
NCT06701201CI-TRIAL-00120417enrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SynKIR-110 | Drug | — | UNRESOLVED |
| SynKIR-310 | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- SynKIR-110
- description
- Participants who previously received SynKIR-110 in an interventional trial
- interventionNames
- Drug: SynKIR-110
- label
- SynKIR-310
- description
- Participants who previously received SynKIR-310 in an interventional trial
- interventionNames
- Drug: SynKIR-310
Primary outcomes (2)
- measure
- To monitor the long-term safety of participants that have been infused with a SynKIR CAR T cell product
- timeFrame
- Up to 15 years from SynKIR CAR T cell product administration
- description
- Frequency and severity of delayed AEs considered related to SynKIR CAR T cell product
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Participants are eligible to be included in the study only if all of the following criteria apply: 1. All adult participants who have received any amount of SynKIR CAR T cell product in a study sponsored by Verismo Therapeutics. 2. Participant is willing and able to comply with the study requirements. Exclusion Criteria: There are no specific exclusion criteria.
References
Publications (0)
Data not yet available
No reference posted for this study.